These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8573230)

  • 1. Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.
    Wildfeuer A; Seidl HP
    Arzneimittelforschung; 1995 Jul; 45(7):819-21. PubMed ID: 8573230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
    Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic sesquiterpenes released by Candida albicans inhibit growth of dermatophytes.
    Brasch J; Horter F; Fritsch D; Beck-Jendroschek V; Tröger A; Francke W
    Med Mycol; 2014 Jan; 52(1):46-55. PubMed ID: 23902158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L., Apiaceae).
    Kosalec I; Pepeljnjak S; Kustrak D
    Acta Pharm; 2005 Dec; 55(4):377-85. PubMed ID: 16375827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
    Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
    Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
    Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
    FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
    Arai R; Sugita T; Nishikawa A
    Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
    J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
    Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G
    J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of Candida albicans fluconazole--resistant mutation strains].
    Wang W; Zhang B; Wang X; Liu Y; Wang D
    Wei Sheng Wu Xue Bao; 1997 Jun; 37(3):212-6. PubMed ID: 9863212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of fluconazole in the skin after oral medication.
    Wildfeuer A; Faergemann J; Laufen H; Pfaff G; Zimmermann T; Seidl HP; Lach P
    Mycoses; 1994; 37(3-4):127-30. PubMed ID: 7845418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance.
    MacNeill C; Weisz J; Carey JC
    J Reprod Med; 2003 Feb; 48(2):63-8. PubMed ID: 12621787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.